Health Movement
Health Made Simple
Apps
Steps
Fitness, coming later
Facts over Fear Free Tools Programs Apparel Free Roadmap
The claim

“Chondroitin relieves osteoarthritis pain.”

Overhyped
Evidence confidence Moderate
The short answer

Chondroitin eases osteoarthritis pain only slightly on average, and the better trials found a difference too small for most people to notice.

What this means for you

Chondroitin gives most people too little pain relief to notice. It is not the reliable pain reliever it is often sold as.

Your next step

If you are thinking about chondroitin, ask your clinician about treatments with stronger evidence for osteoarthritis pain first. If you already take it and do not notice a clear difference, you can stop.

Who should be careful?

Safety note: Chondroitin taken with glucosamine has been linked to bleeding in people taking the blood thinner warfarin, so ask your pharmacist before combining them. Many products also contain glucosamine, which may raise blood sugar in some people. Little is known about safety during pregnancy or breastfeeding.

Talk to a healthcare professional if: you take warfarin, you have diabetes and are considering a product that also contains glucosamine, you are pregnant or breastfeeding, or joint pain is keeping you from daily activities.

The evidence
Why this confidence?

The largest and best-run trials agree that chondroitin's effect on pain is small, about the same size as glucosamine's and below what most patients notice. Confidence is Moderate because many smaller positive trials are low quality and their results vary widely.

The facts

Chondroitin eases osteoarthritis pain only slightly on average, and the better trials found a difference too small for most people to notice. In the two best-quality trials (1,253 people), 53 in 100 people on chondroitin had at least a 20% drop in knee pain, compared with 47 in 100 on a placebo pill.

The bigger picture

A Cochrane review of 43 trials found less pain with chondroitin in short studies, but that evidence was low quality and results varied a lot between trials. The benefit became uncertain when the review looked only at larger or better-designed trials, or trials without drug-company funding. In the US GAIT trial of 1,583 people, 65.4% on chondroitin had at least 20% less pain after 24 weeks, compared with 60.1% on placebo, a gap that could be due to chance. A pooled analysis of the 10 largest trials found chondroitin lowered pain by 0.3 points on a 10-point scale, less than the 0.9 points most patients would notice. Among the better studies, one pharmaceutical-grade product did better than other brands.

What Guidelines Say

The American College of Rheumatology and Arthritis Foundation (2019) strongly recommend against chondroitin for knee and hip osteoarthritis. They conditionally recommend it for hand osteoarthritis, based on a single trial. The Osteoarthritis Research Society International (2019) strongly recommends against it for knee osteoarthritis because the evidence is low quality. The American Academy of Orthopaedic Surgeons (2021) lists it as possibly helpful, with inconsistent evidence. A European expert group (ESCEO, 2019) supports only prescription chondroitin sulfate.

Last reviewed 2026-10-20 We update these cards as new research comes out. When the evidence changes, our verdicts change too.
Suggest a correction →